Coaptation Assistance Element for Transcatheter Mitral Regurgitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for mitral valve regurgitation, including pharmacological and surgical options, are invasive, costly, and dependent on operator skill, with a need for less invasive, reliable, and easily deployable devices that enhance leaflet coaptation without disrupting anatomy.
Innovation Solution
A coaptation assistance element that remains within the blood flow path, conformable, and extends laterally across the valve opening, with anchors that engage tissue for deployment and retrieval, allowing for simple and reliable treatment of mitral valve regurgitation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surgical options are used to treat mitral valve regurgitation, then treatment effectiveness is improved, but patient trauma and invasiveness increase
Solution Approach 1:
The patent replaces traditional surgical mechanical intervention with a transcatheter delivery system that uses a delivery catheter to implant the coaptation assistance element through a minimally invasive approach, substituting open-heart surgery with a less invasive catheter-based procedure
Solution Approach 2:
The delivery catheter serves as an intermediary tool that enables the coaptation assistance element to be deployed through a minimally invasive transcatheter approach, mediating between the operator and the heart valve without requiring open surgical access
2Reliability
If complex surgical procedures are used, then treatment reliability is improved, but operator skill dependency increases
Solution Approach 1:
The device is segmented into distinct functional components including the coaptation assistance element, anchors, and delivery catheter system, allowing for standardized deployment procedures that reduce operator skill dependency while maintaining treatment reliability
Solution Approach 2:
The coaptation assistance element with its anchors is designed to self-engage with the valve tissue upon deployment, reducing the need for complex manual manipulation by the operator and thereby reducing skill dependency while maintaining reliable treatment outcomes
3Reliability
If traditional surgical methods are used, then valve function is improved, but procedure cost and complexity increase
Solution Approach 1:
The patent extracts the essential coaptation function from complex surgical procedures by isolating it into a dedicated coaptation assistance element that can be deployed independently through a simplified transcatheter approach, reducing overall procedure complexity while maintaining valve function improvement
Data Source
AI summary
The invention relates to a device for use in the transcatheter treatment of mitral valve regurgitation, specifically a coaptation assistance element for implantation across the valve; a system including the coaptation assistance element and anchors for implantation; a system including the coaptation assistance element and delivery catheter; and a method for transcatheter implantation of a coaptation element across a heart valve.


